Clinical Trial Update: Novel Triple-dose Tuberculosis Retreatment Regimen [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a novel triple-dose retreatment regimen for multidrug-resistant and pulmonary tuberculosis is currently recruiting in Belgiu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis
• Pulmonary Tuberculosis
• Tuberculosis

Snippet

Sponsor: Institute of Tropical Medicine, Belgium | Conditions: Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis | Phase 3 | Status: RECRUITING